» Articles » PMID: 34710535

Role of Toll-like Receptor 4 and Sex in 6-hydroxydopamine-induced Behavioral Impairments and Neurodegeneration in Mice

Abstract

Parkinson's disease (PD) is a neurodegenerative disease characterized by progressive loss of the nigrostriatal dopaminergic neurons that are associated with motor alterations and non-motor manifestations (such as depression). Neuroinflammation is a process with a critical role in the pathogenesis of PD. In this regard, toll-like receptor 4 (TLR4) is a central mediator of immune response in PD. Moreover, there are gender-related differences in the incidence, prevalence, and clinical features of PD. Therefore, we aimed to elucidate the role of TLR4 in the sex-dependent response to dopaminergic denervation induced by 6-hydroxydopamine (6-OHDA) in mice. Female and male adult wildtype (WT) and TLR4 knockout (TLR4) mice were administered with unilateral injection of 6-OHDA in the dorsal striatum, and non-motor and motor impairments were evaluated for 30 days, followed by biochemistry analysis in the substantia nigra pars compacta (SNc), dorsal striatum, and dorsoventral cortex. Early non-motor impairments (i.e., depressive-like behavior and spatial learning deficits) induced by 6-OHDA were observed in the male WT mice but not in male TLR4 or female mice. Motor alterations were observed after administration of 6-OHDA in both strains, and the lack of TLR4 was also related to motor commitment. Moreover, ablation of TLR4 prevented 6-OHDA-induced dopaminergic denervation and microgliosis in the SNc, selectively in female mice. These results reinforced the existence of sex-biased alterations in PD and indicated TLR4 as a promising therapeutic target for the motor and non-motor symptoms of PD, which will help counteract the neuroinflammatory and neurodegenerative processes.

Citing Articles

Challenges and Opportunities in Exploring Non-Motor Symptoms in 6-Hydroxydopamine Models of Parkinson's Disease: A Systematic Review.

Prates-Rodrigues M, Schweizer B, de Paula Gomes C, Ribeiro A, Padovan-Neto F, Masini D J Neurochem. 2025; 169(2):e70008.

PMID: 39901598 PMC: 11791392. DOI: 10.1111/jnc.70008.


Subthalamic nucleus but not entopeduncular nucleus deep brain stimulation enhances neurogenesis in the SVZ-olfactory bulb system of Parkinsonian rats.

Fauser M, Payonk J, Weber H, Statz M, Winter C, Hadar R Front Cell Neurosci. 2024; 18:1396780.

PMID: 38746080 PMC: 11091264. DOI: 10.3389/fncel.2024.1396780.


Toll-Like Receptor 4 Plays a Significant Role in the Biochemical and Neurological Alterations Observed in Two Distinct Mice Models of Huntington's Disease.

Martinez-Gopar P, Perez-Rodriguez M, Angeles-Lopez Q, Tristan-Lopez L, Gonzalez-Espinosa C, Perez-Severiano F Mol Neurobiol. 2023; 60(5):2678-2690.

PMID: 36701109 DOI: 10.1007/s12035-023-03234-w.


Therapeutic Approaches to Non-Motor Symptoms of Parkinson's Disease: A Current Update on Preclinical Evidence.

Weerasinghe-Mudiyanselage P, Kang S, Kim J, Moon C Curr Neuropharmacol. 2022; 21(3):560-577.

PMID: 36200159 PMC: 10207906. DOI: 10.2174/1570159X20666221005090126.


Inflammatory Animal Models of Parkinson's Disease.

Garcia-Revilla J, Herrera A, de Pablos R, Venero J J Parkinsons Dis. 2022; 12(s1):S165-S182.

PMID: 35662128 PMC: 9535574. DOI: 10.3233/JPD-213138.